Clinical trial
Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in…
NCT00417612 · Yale University, Other · Completed
Key facts
| NCT number | NCT00417612 |
|---|---|
| Title | Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets |
| Official title | The Role of Parathyroid Hormone in the Pathogenesis of Skeletal Disease in X-linked Hypophosphatemic Rickets (XLH) |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypophosphatemia, Familial, Hyperparathyroidism |
| Intervention type | Drug, Other |
| Interventions | Paricalcitol, Placebo |
| Enrollment | 33 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Jan 1, 2007 |
| Last update posted | Mar 17, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: